Sermorelin (GRF 1-29 NH₂) is the only compound in the buying guides cluster with a former FDA approval — approved as Geref in 1997 for pediatric GH deficiency, commercially discontinued in 2008 for manufacturing reasons, and now available through compounding pharmacies or as a research-grade compound. It shares the same GHRH receptor target as CJC-1295 (without DAC) but differs at 4 amino acid positions — a source of frequent buyer confusion.
This article applies 7 verification checks to sermorelin using data from Peptigrity's independent lab tests, community reviews, and reviewed peptide shops. Peptigrity does not sell peptides or recommend vendors.
What Is Sermorelin and Why Was It Once FDA-Approved?
Sermorelin is a synthetic 29-amino-acid peptide representing the first 29 residues of native 44-amino-acid GHRH — the shortest fully functional fragment — FDA-approved as Geref in 1997 for diagnosing and treating pediatric GH deficiency, then discontinued by the manufacturer in 2008 for commercial reasons, not safety concerns.
MW ~3,357.9 Da. CAS: 86168-78-7. Sermorelin binds the GHRH receptor (GHRHR) on pituitary somatotrophs, activating adenylate cyclase → cAMP/PKA signalling → GH synthesis and pulsatile release. The pulsatile pattern is physiological — regulated by somatostatin negative feedback, making overdose difficult unlike exogenous recombinant human GH.
The half-life is very short: approximately 10–20 minutes. This is a feature, not a deficiency — it preserves the body's natural GH pulsatility. Research dosing involves 1–3 administrations per day. The review "Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?" (Walker, Clin Interv Aging 2006) positioned sermorelin as an alternative to direct rhGH administration, supporting pituitary function rather than bypassing it.
Sermorelin is most commonly paired with Ipamorelin for dual-receptor synergy: sermorelin targets GHRHR (pulse amplitude) while Ipamorelin targets GHSR (pulse frequency). Two different receptors, two signalling cascades, one synergistic outcome.
A compound-specific quality concern: sermorelin contains methionine at position 27 (Met27). Methionine oxidises to methionine sulfoxide under heat, light, or improper storage — the same concern documented for BPC-157 (1 Met) and MOTS-C (2 Met). Prompt freezer storage on arrival matters.
Regulatory status: sermorelin is no longer commercially available as an FDA-approved product. It remains available through compounding pharmacies with a physician's prescription (the regulated pathway) and through RUO vendors (the unregulated pathway). Not currently on FDA Category 2. Not WADA-prohibited.
Sermorelin vs CJC-1295: Same Receptor, Different Molecules
Sermorelin and CJC-1295 (no DAC) both target the GHRH receptor but differ at 4 amino acid positions — most critically at position 27, where sermorelin retains methionine (oxidation-susceptible) and CJC-1295 substitutes leucine (oxidation-resistant).
Property | Sermorelin | CJC-1295 no DAC |
|---|---|---|
Sequence | Native GHRH(1-29) NH₂ | Modified GHRH(1-29) — 4 substitutions |
Key substitutions | None (native) | D-Ala², Gln⁸, Ala¹⁵, Leu²⁷ |
MW | ~3,357.9 Da | ~3,367.9 Da |
Half-life | ~10–20 min | ~30 min |
Position 27 | Met (oxidation-susceptible) | Leu (oxidation-resistant) |
FDA history | Approved 1997, discontinued 2008 | Never approved |
The MW difference is only ~10 Da. Standard-resolution MS can differentiate them, but the margin is small. HPLC retention time differences are more reliable for distinguishing the two compounds in practice.
Buyer confusion exists: some vendors use "sermorelin" and "CJC-1295 no DAC" interchangeably. They are not the same molecule. 4 amino acids differ. The substitutions in CJC-1295 were specifically engineered to resist enzymatic degradation and prevent Met27 oxidation. Confirm which compound the CoA MW matches before ordering.
Why choose sermorelin: former FDA approval validates the molecule's biological activity, available through compounding pharmacies, better-studied in human clinical contexts. Why choose CJC-1295 no DAC: improved stability (no Met27), longer half-life, fewer administrations per day.
7 Things to Check Before Ordering Sermorelin
The same 7 checks apply — with sermorelin, pay particular attention to Met27 oxidation (same concern as BPC-157) and MW confirmation distinguishing sermorelin (~3,357.9 Da) from CJC-1295 no DAC (~3,367.9 Da).
1. Third-Party HPLC Purity (≥98%)
HPLC detects Met27 oxidation products — methionine sulfoxide variants appearing as secondary peaks near the main sermorelin peak. The same analytical concern applies to BPC-157 and MOTS-C. Cross-reference on peptigrity.com/lab-tests — filter by "Sermorelin." The study "Peptide Impurities in Commercial Synthetic Peptides" (PMC2238048) demonstrated that contamination at 1% produced measurable biological effects.
2. Mass Spectrometry Identity (~3,357.9 Da)
MS distinguishes sermorelin (~3,357.9 Da) from CJC-1295 no DAC (~3,367.9 Da) — a ~10 Da difference detectable by standard instruments. Also distinguishes from CJC-1295 with DAC (significantly higher MW). If you ordered sermorelin but MS shows ~3,367.9 Da, you received CJC-1295 no DAC — a different compound with different substitutions, different stability, and different half-life. See Mass Spectrometry for Peptides: Verifying Identity & Molecular Weight for the methodology.
3. CoA From a Named, Verifiable Lab
Verify through the lab's portal: Janoshik (Task #), Chromate (QR code + Job Number), Freedom Diagnostics (online system). For sermorelin: confirm the CoA specifies "Sermorelin" or "GRF 1-29" — not "CJC-1295" or "Mod GRF 1-29." The MW should match ~3,357.9 Da. See Red Flags in Peptide Certificates of Analysis for the fraud detection checklist.
4. Independent Data on Peptigrity
Search peptigrity.com/lab-tests for the vendor + Sermorelin. Check the shop's profile on peptigrity.com/shops — trust score, ✓ Lab Verified badge, and test count. Independent community-submitted data carries more weight than vendor-published CoAs.
5. Community Reviews
Read reviews on the vendor's Peptigrity page. Each includes 5 sub-ratings: Quality, Delivery, Pricing, Customer Service, and Product Accuracy. GH-axis buyers often compare sermorelin with CJC-1295 — look for compound-specific mentions confirming which molecule was actually received.
6. Vial Presentation and Storage
Lyophilised sermorelin should be a white to off-white powder. Not lipidated, but Met27 makes it oxidation-susceptible. Store at −20°C immediately on arrival. Protect from light. The Met27 oxidation concern gives sermorelin the same storage urgency as BPC-157 and MOTS-C. After reconstitution: 2–8°C, use within 28 days. Sermorelin's ~10–20 minute half-life means reconstituted solution degrades faster than CJC-1295 — prompt use after reconstitution matters. Ambient shipping is acceptable for short transit of lyophilised powder.
7. Pricing Reality Check
Research-grade sermorelin pricing (March 2026):
2 mg vial: $20–50.
5 mg vial: $40–80.
10 mg vial: $55–100.
Below $15 for 2 mg is suspicious. Pricing should be comparable to CJC-1295 no DAC at the same vendor — both are 29-amino-acid GHRH analogs with similar synthesis complexity. If sermorelin costs significantly more or less than CJC-1295 at the same vendor, ask why. See Peptide Purity Standards: What Percentage Is Actually Acceptable? for the quality-price framework.
Sermorelin on Peptigrity's Lab Test Database
Filter by Sermorelin at peptigrity.com/lab-tests to compare independent purity data across vendors before ordering.
Community-submitted data from third-party laboratories represents real products from real buyers. Use the data before ordering. Browse the Sermorelin peptide guide for the compound profile alongside lab data.
Frequently Asked Questions
What purity should research-grade sermorelin have?
≥98% HPLC from a third-party lab. Sermorelin contains Met27 — check HPLC for oxidation-related secondary peaks near the main peak. Cross-reference on peptigrity.com/lab-tests.
How much does research-grade sermorelin cost?
$20–50 for 2 mg, $40–80 for 5 mg, $55–100 for 10 mg. Below $15 for 2 mg is suspicious. Pricing should be comparable to CJC-1295 no DAC — both are 29-amino-acid GHRH analogs. Compare across vendors on peptigrity.com/shops.
Is sermorelin the same as CJC-1295?
No. Both are 29-amino-acid GHRH analogs targeting the same receptor, but sermorelin is the native GHRH(1-29) sequence while CJC-1295 no DAC has 4 amino acid substitutions — including Leu27 replacing Met27 (eliminating oxidation susceptibility). MW differs by ~10 Da. Half-life differs (~10–20 min vs ~30 min). They are not interchangeable. Confirm which compound the CoA MW matches.
Was sermorelin FDA-approved?
Yes — approved as Geref in 1997 for diagnosing and treating pediatric GH deficiency. The manufacturer discontinued it in 2008 for commercial/manufacturing reasons, not safety concerns. This former approval validates the molecule's biological activity but does NOT validate current RUO vendor products. Sermorelin remains available through compounding pharmacies with a physician's prescription.
Should I buy sermorelin or CJC-1295?
Depends on the research objective. Sermorelin: former FDA approval validates the molecule, available through compounding pharmacies, better human clinical data, more oxidation-susceptible (Met27). CJC-1295 no DAC: improved stability (Leu27), longer half-life, fewer daily administrations. Both target the same receptor. Verify whichever you choose on peptigrity.com/lab-tests.
For the complete buyer verification framework, see How to Verify Peptide Quality Before You Buy and What to Look for in a Peptide Shop: A Buyer's Checklist. Browse all peptide shops ranked by trust score.
This article is for educational and informational purposes only and does not constitute medical advice. Sermorelin was formerly FDA-approved as Geref (discontinued 2008). Research-grade sermorelin from RUO vendors is not equivalent to the discontinued pharmaceutical product. Sermorelin remains available through compounding pharmacies with a physician's prescription. Always consult a qualified healthcare provider before using any peptide or research compound. Peptigrity is an independent review platform and does not sell, endorse, or recommend specific products or vendors.
